Skip to main content
Alok Kothari, MD, Pediatric Hematology & Oncology, Phoenix, AZ, Phoenix Children's

AlokKirankumarKothariMD

Pediatric Hematology & Oncology Phoenix, AZ

Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology

Staff Physician Hematology Oncology

Dr. Kothari is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kothari's full profile

Already have an account?

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Pediatric Hematology/Oncology, 2012 - 2015
  • Baylor College of Medicine (Houston)
    Baylor College of Medicine (Houston)Residency, Pediatrics, 2009 - 2012
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 2009
  • Washington University in St. Louis
    Washington University in St. LouisB.A., Biology and Mathematics, 2000 - 2003

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 2020 - 2025
  • MO State Medical License
    MO State Medical License 2012 - 2021
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Ruth L Kirschstein National Research Service Award 2013-2016

Publications & Presentations

PubMed

Journal Articles

  • Granulomatous dermatitis secondary to vemurafenib in a child with Langerhans cell histiocytosis  
    Chen L, His AC, Kothari A, Dehner LP, Hayashi RJ, Coughlin CC, Pediatr Dermatol, 1/1/2018
  • Dnmt3a regulates T-cell development and supress T-ALL transformation  
    Kramer AC, Kothari A, Wilson WC, Celik H, Nikitas J, Mallaney C, Ostrander EL, Eultgen E, Martens A, Valentine MC, Young AL, Druley TE, Figueroa ME, Zhang B, Challen GA, Leukemia, 1/1/2017
  • Enforced differention of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation  
    Celik H, Mallaney C, Kothari A, Ostrander EL, Eultgen E, Martens A, Miller CA, Hundal J, Klco JM, Challen GA, Blood, 1/1/2015
  • Join now to see all

Hospital Affiliations